Related Experiment Video
Updated: Jun 11, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Fever and reversible laboratory abnormalities associated with prolonged use of piperacillin/tazobactam: A case report
1Department of Respiratory Medicine, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Hangzhou, Zhejiang, China.
Abstract:
Piperacillin/tazobactam is a widely used anti-infective agent. However, prolonged use can lead to adverse drug reactions, primarily presenting as fever and various abnormal laboratory test results. Certain abnormal test outcomes may mislead clinical assessments. We present a case of a 50-year-old Chinese woman who developed a fever and abnormal blood tests after receiving piperacillin/tazobactam for more than 2 weeks. These tests showed elevated levels of C-reactive protein, procalcitonin, transaminases, myocardial enzymes, and a significant increase in D-dimer. After stopping piperacillin/tazobactam, all relevant test results returned to normal within 10 days. It is imperative for clinicians to be vigilant of this adverse effect in patients undergoing extended piperacillin/tazobactam treatment, as early recognition can prevent unnecessary diagnostic tests and therapeutic interventions.
Insights
Prolonged piperacillin/tazobactam use can cause drug reactions, including fever and misleading lab results. Stopping the antibiotic resolved these abnormalities, highlighting the need for clinical vigilance.
Area of Science:
- Pharmacology
- Clinical Medicine
- Infectious Diseases
Background:
- Piperacillin/tazobactam is a broad-spectrum antibiotic frequently used for serious infections.
- Prolonged administration of piperacillin/tazobactam is associated with potential adverse drug reactions.
- Abnormal laboratory findings during treatment can complicate clinical decision-making.
More Related Videos
08:30One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures
Published on: July 9, 2012
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Pyelonephritis I: Introduction
Increased Body Temperature
Patterns of Fever
Urine Studies II: Urine Culture and Sensitivity Test
Pneumonia III: Complications and Assessment